Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Taiho Oncology Europe Gmbh

02 1Taiho Pharma Netherlands B.V.

03 3Taiho Pharma Netherlands Bv

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Futibatinib

Brand Name : Lytgobi

Dosage Form : Film Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 08/10/2024

Application Number : 69714

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

02

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Futibatinib

Brand Name : Lytgobi

Dosage Form : Film-Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

03

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Futibatinib

Brand Name : Lytgobi

Dosage Form : Film Coated Tablet

Dosage Strength : 4MG

Packaging :

Approval Date : 21-09-2023

Application Number : 1231741001

Regulatory Info : Authorized

Registration Country : Spain

blank

04

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Futibatinib

Brand Name : Lytgoby

Dosage Form : Film Coated Tablet

Dosage Strength :

Packaging :

Approval Date : 04-07-2023

Application Number : 28106780922

Regulatory Info : Prescription

Registration Country : Denmark

blank

05

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Futibatinib

Brand Name : Lytgoby

Dosage Form : Film Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 04-07-2023

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank